000			02164 a2200565 4500
005			20250517121140.0
264		0	_c20170501
008			201705s 0 0 eng d
022			_a1879-1913
024	7		_a10.1016/j.amjcard.2016.08.072 _2doi
040			_aNLM _beng _cNLM
100	1		_aJones, Peter H
245	0	0	_aSafety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials. _h[electronic resource]
260			_bThe American journal of cardiology _cDec 2016
300			_a1805-1811 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAcute Coronary Syndrome _xepidemiology
650	0	4	_aAged
650	0	4	_aAngina, Unstable _xepidemiology
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAnticholesteremic Agents _xadverse effects
650	0	4	_aBack Pain _xchemically induced
650	0	4	_aClinical Trials, Phase II as Topic
650	0	4	_aClinical Trials, Phase III as Topic
650	0	4	_aComorbidity
650	0	4	_aCoronary Disease _xepidemiology
650	0	4	_aDiabetes Mellitus, Type 2 _xepidemiology
650	0	4	_aEzetimibe _xadverse effects
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use
650	0	4	_aHypercholesterolemia _xdrug therapy
650	0	4	_aInfluenza, Human _xchemically induced
650	0	4	_aMiddle Aged
650	0	4	_aMyocardial Infarction _xepidemiology
650	0	4	_aNasopharyngitis _xchemically induced
650	0	4	_aPruritus _xchemically induced
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRespiratory Tract Infections _xchemically induced
650	0	4	_aStroke _xepidemiology
650	0	4	_aUrinary Tract Infections _xchemically induced
700	1		_aBays, Harold E
700	1		_aChaudhari, Umesh
700	1		_aPordy, Robert
700	1		_aLorenzato, Christelle
700	1		_aMiller, Kathryn
700	1		_aRobinson, Jennifer G
773	0		_tThe American journal of cardiology _gvol. 118 _gno. 12 _gp. 1805-1811
856	4	0	_uhttps://doi.org/10.1016/j.amjcard.2016.08.072 _zAvailable from publisher's website
999			_c26505286 _d26505286